세계의 아포토시스(Apoptosis) 어세이 시장 보고서(2025년)
Apoptosis Assay Kit Global Market Report 2025
상품코드 : 1824333
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

아포토시스(Apoptosis) 어세이 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.6%를 나타내 107억 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 만성질환의 유병률 상승, 맞춤형 의료의 중시의 높아짐, 질병의 조기 발견의 중시의 높아짐, 재료가공산업의 진보, 암 연구의 고조에 기인하고 있습니다. 예측 기간의 주요 동향으로는 연구활동 증가, 아폽토시스 검출의 기술적 진보, 안전성 및 품질관리의 중시 증가, 하이스루풋 스크리닝의 중시 증가, 멀티플렉스 어세이 수요 증가 등이 있습니다.

향후 5년간의 성장률 11.6%라는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 영국이나 싱가포르에서 수입되는 유동세포계측 세포사멸 키트와 카스파제 활성 분석의 비용을 상승시키고, 암 연구를 늦추거나 학술 연구소의 운영비를 상승시킬 수 있기 때문에 미국의 생물의학 연구를 혼란시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

아포토시스(Apoptosis) 어세이 시장 예상 성장은 감염 및 만성 질환의 유병률 증가에 의해 촉진될 것으로 예측됩니다. 박테리아, 바이러스, 곰팡이, 기생충과 같은 병원성 미생물에 의해 유발되는 감염과 당뇨병과 같은 장기간의 건강 상태의 개발을 특징으로 하는 만성 질환은 연구 환경에서 아폽토시스 분석의 이용을 촉진하고 있습니다. 이러한 분석은 감염과 만성 질환의 근본적인 메커니즘을 조사하고 병원체의 영향을 연구하는 데 도움이 됩니다. 예를 들어, 2023년 1월 기준, National Center for Biotechnology Information(NCBI)은 50세 이상에서 하나 이상의 만성 질환을 가진 사람의 수가 99.5% 증가했고 2050년에는 1억 4,266만 명에 이를 것으로 예측하고 있다고 보고했습니다. 게다가 2022년 7월 호주 보건복지연구소(AIHW)는 호주에서는 약 47%에 해당하는 1,160만명이 선정된 10개의 만성질환 중 적어도 하나를 앓고 있다고 추정했습니다. 그 결과 감염과 만성 질환의 이환율 증가가 아포토시스(Apoptosis) 어세이 시장 성장 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

An apoptosis assay kit is designed for the detection of active caspases in cells through the use of a cell-permeable, non-cytotoxic reagent. This kit is employed to identify and quantify apoptosis, a programmed cell death process, within biological samples.

The primary components of apoptosis assay kits include kits, reagents, instruments, and other related items. A kit comprises a collection of items kept together, often stored in a single container, and apoptosis assay kits find application in various fields such as life science research, drug discovery and development, and environmental monitoring. Their uses encompass screening for potential drug candidates, investigating disease pathways, and evaluating biopharmaceutical production processes. Different assays, including caspase assay, DNA fragmentation assay, cell permeability assay, and mitochondrial assay, are conducted using diverse detection techniques such as flow cytometry, cell imaging and analysis systems, spectrophotometry, and other methods. These kits serve various purposes in drug discovery and development, clinical research, stem cell research, and basic research, catering to end-users such as pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The apoptosis assay kit research report is one of a series of new reports from The Business Research Company that provides apoptosis assay kit market statistics, including the apoptosis assay kit industry's global market size, regional shares, competitors with a apoptosis assay kit market share, detailed apoptosis assay kit market segments, market trends and opportunities, and any further data you may need to thrive in the apoptosis assay kit industry. This apoptosis assay kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The apoptosis assay kit market size has grown strongly in recent years. It will grow from $6.3 billion in 2024 to $6.91 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, growth on emphasis on personalized medicine, rise in demand for drug discovery and development, growth on emphasis on early disease detection, growth of automation in laboratories.

The apoptosis assay kit market size is expected to see rapid growth in the next few years. It will grow to $10.7 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, growing emphasis on personalized medicine, growing emphasis on early disease detection, advancements in material processing industries, rising cancer research. Major trends in the forecast period include increasing research activities, technological advancements in apoptosis detection, growing emphasis on safety and quality control, growing emphasis on high-throughput screening, increasing demand for multiplex assays.

The forecast of 11.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. biomedical research by increasing costs for flow cytometry apoptosis kits and caspase activity assays imported from the UK and Singapore, potentially slowing cancer research and raising academic lab operational expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the apoptosis assay kit market is expected to be propelled by the increasing prevalence of infectious and chronic diseases. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, and chronic diseases, characterized by long-term health conditions developing over an extended period, such as diabetes, are driving the utilization of apoptosis assays in research settings. These assays help investigate the underlying mechanisms of infectious and chronic diseases and study the impacts of pathogens. For instance, as of January 2023, the National Center for Biotechnology Information (NCBI) reported that the number of individuals aged 50 years and older with one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050. Additionally, in July 2022, the Australian Institute of Health and Welfare (AIHW) estimated that approximately 47%, or 11.6 million individuals in Australia, were affected by at least one of the ten selected chronic ailments. Consequently, the increasing incidence of infectious and chronic diseases is a key driver of the apoptosis assay kit market's growth.

The growing demand in the pharmaceutical industry is expected to contribute to the expansion of the apoptosis assay kit market. The pharmaceutical industry, engaged in the research, development, production, and marketing of drugs and medications for medical treatment, relies on apoptosis assay kits for studying and evaluating the process of apoptosis in cells. Researchers and drug developers utilize these kits to advance targeted and effective therapeutic interventions. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that the total pharmaceutical production in Europe reached $384,200 million (€340,000 million) in 2022, reflecting a 4.95% increase from $366,267 million (€323,950 million) in 2021. Therefore, the growing demand in the pharmaceutical industry is a significant driver of the apoptosis assay kit market's growth.

The apoptosis assay kit market is witnessing a notable trend with the advancement in cellular analysis techniques, a trend that major market players are actively embracing to maintain their market standing. For example, in September 2022, Nanolive SA, a biotechnology company based in Switzerland specializing in live cell imaging and analysis technologies, unveiled the LIVE Cell Death Assay. This state-of-the-art tool for cell analysis provides automated profiling of cell health, death, apoptosis, and necrosis. Leveraging advanced machine learning technology, this label-free assay accurately distinguishes between living cells, dead cells, apoptosis, and necrosis. Its user-friendly interface enables easy activation with a single click, offering 13 essential viability and death-related metrics for comprehensive analysis.

Prominent companies in the apoptosis assay kit market are strategically introducing next-generation solutions, including cell invasion assay kits, to gain a competitive advantage. These assay kits play a crucial role in cell biology research, particularly in the study of cancer progression, wound healing, and other processes involving cell migration through extracellular matrices (ECM). In December 2023, TheWell Bioscience, a US-based biotechnology company, launched the VitroGel-Based Cell Invasion Assay Kits, providing unparalleled accuracy, efficiency, and reliability for cell migration assays. The kits can be completed within 30 minutes, a significant improvement compared to hours required by assay kits using animal-based ECM. This innovation aids researchers in studying cell migration and invasion.

In February 2023, VBL Therapeutics, a US-based biotechnology company specializing in targeted therapies for apoptosis, entered into a partnership with Notable Labs. Through this collaboration, VBL Therapeutics aims to focus on developing innovative cancer treatments and advancing precision medicine using artificial intelligence and machine learning technologies. Notable Labs, also a US-based biotechnology company, is part of this strategic partnership.

Major companies operating in the apoptosis assay kit market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck Group, Becton Dickinson and Company, Agilent Technologies Inc., Lonza Group Ltd., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Enzo Life Sciences AG, Cayman Chemical Company, BioVision Inc., Cell Signaling Technology Inc., Santa Cruz Biotechnology Inc., GeneTex Inc., Creative Bioarray, GE Healthcare Bio Sciences AB, Active Motif Inc., Novus Biologicals LLC, BPS Bioscience Inc., RayBiotech Life Inc., Geno Technology Inc., Biotium Inc., GeneCopoeia Inc., Trevigen Inc., AAT Bioquest Inc.

North America was the largest region in the apoptosis assay kit market in 2024. The regions covered in the apoptosis assay kit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the apoptosis assay kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The apoptosis assay kit market consists of sales of the JC-1 assay kit, the cell cycle assay kit, and the enhanced cell counting kit. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Apoptosis Assay Kit Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on apoptosis assay kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for apoptosis assay kit ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The apoptosis assay kit market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Apoptosis Assay Kit Market Characteristics

3. Apoptosis Assay Kit Market Trends And Strategies

4. Apoptosis Assay Kit Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Apoptosis Assay Kit Growth Analysis And Strategic Analysis Framework

6. Apoptosis Assay Kit Market Segmentation

7. Apoptosis Assay Kit Market Regional And Country Analysis

8. Asia-Pacific Apoptosis Assay Kit Market

9. China Apoptosis Assay Kit Market

10. India Apoptosis Assay Kit Market

11. Japan Apoptosis Assay Kit Market

12. Australia Apoptosis Assay Kit Market

13. Indonesia Apoptosis Assay Kit Market

14. South Korea Apoptosis Assay Kit Market

15. Western Europe Apoptosis Assay Kit Market

16. UK Apoptosis Assay Kit Market

17. Germany Apoptosis Assay Kit Market

18. France Apoptosis Assay Kit Market

19. Italy Apoptosis Assay Kit Market

20. Spain Apoptosis Assay Kit Market

21. Eastern Europe Apoptosis Assay Kit Market

22. Russia Apoptosis Assay Kit Market

23. North America Apoptosis Assay Kit Market

24. USA Apoptosis Assay Kit Market

25. Canada Apoptosis Assay Kit Market

26. South America Apoptosis Assay Kit Market

27. Brazil Apoptosis Assay Kit Market

28. Middle East Apoptosis Assay Kit Market

29. Africa Apoptosis Assay Kit Market

30. Apoptosis Assay Kit Market Competitive Landscape And Company Profiles

31. Apoptosis Assay Kit Market Other Major And Innovative Companies

32. Global Apoptosis Assay Kit Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Apoptosis Assay Kit Market

34. Recent Developments In The Apoptosis Assay Kit Market

35. Apoptosis Assay Kit Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기